Keswani Sanjay Chandru

US insider· US
Sign in for alerts
  • ACQUIREDT+30

    Neurocrine Biosciences Inc · NASDAQ

    +3,914 sh

    Filed 15 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    Neurocrine Biosciences Inc · NASDAQ

    −2,112 sh · $329.9K

    Filed 15 Sept 2026SEC Form 4view source